13F HOLDINGS REPORT
Cormorant Asset Management, LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001583977-25-000001
Total Value
$1.82B
Positions
48
Other Managers
1
Confidential Omitted
No
Holdings (48)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 8,494,151 | $460.0M | 25.26% |
| 2 | PRAXIS PRECISION MEDICINES I | PRAX | 1,693,219 | $130.3M | 7.16% |
| 3 | JANUX THERAPEUTICS INC | JANX | 2,100,000 | $112.4M | 6.17% |
| 4 | ARCELLX INC | ACLX | 1,300,000 | $99.7M | 5.48% |
| 5 | EDGEWISE THERAPEUTICS INC | EWTX | 3,406,534 | $91.0M | 5.00% |
| 6 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 3,250,000 | $83.5M | 4.59% |
| 7 | EYEPOINT PHARMACEUTICALS INC | EYPT | 8,325,000 | $62.0M | 3.41% |
| 8 | RAPPORT THERAPEUTICS INC | RAPP | 2,940,921 | $52.2M | 2.87% |
| 9 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,000,000 | $51.1M | 2.81% |
| 10 | INSMED INC | INSM | 650,000 | $44.9M | 2.46% |
| 11 | BRIDGEBIO PHARMA INC | BBIO | 1,600,000 | $43.9M | 2.41% |
| 12 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,561,600 | $42.9M | 2.36% |
| 13 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 1,059,331 | $38.2M | 2.10% |
| 14 | VAXCYTE INC | PCVX | 425,000 | $34.8M | 1.91% |
| 15 | MERUS N V | N5749R100 | 740,000 | $31.1M | 1.71% |
| 16 | HELIX ACQUISITION CORP II | HLXC | 2,909,000 | $30.5M | 1.68% |
| 17 | AVIDITY BIOSCIENCES INC | 05370A108 | 1,050,000 | $30.5M | 1.68% |
| 18 | PHARVARIS N V | PHVS | 1,466,460 | $28.1M | 1.54% |
| 19 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 2,375,000 | $28.0M | 1.54% |
| 20 | TARSUS PHARMACEUTICALS INC | TARS | 500,000 | $27.7M | 1.52% |
| 21 | AXSOME THERAPEUTICS INC | AXSM | 325,000 | $27.5M | 1.51% |
| 22 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 1,825,000 | $25.4M | 1.40% |
| 23 | RHYTHM PHARMACEUTICALS INC | RYTM | 400,000 | $22.4M | 1.23% |
| 24 | CG ONCOLOGY INC | CGON | 775,000 | $22.2M | 1.22% |
| 25 | CARGO THERAPEUTICS INC | 14179K101 | 1,182,563 | $17.1M | 0.94% |
| 26 | ALUMIS INC | ALMS | 2,147,396 | $16.9M | 0.93% |
| 27 | ONKURE THERAPEUTICS INC | OKUR | 1,837,739 | $15.8M | 0.87% |
| 28 | ARRIVENT BIOPHARMA INC | AVBP | 585,462 | $15.6M | 0.86% |
| 29 | ABIVAX SA | AAVXF | 2,130,000 | $15.6M | 0.86% |
| 30 | ENGENE HOLDINGS INC | ENGNW | 2,323,595 | $15.5M | 0.85% |
| 31 | BIOAGE LABS INC | BIOA | 2,629,529 | $15.2M | 0.84% |
| 32 | BIOMEA FUSION INC | BMEA | 3,570,872 | $13.9M | 0.76% |
| 33 | MBX BIOSCIENCES INC | MBX | 700,000 | $12.9M | 0.71% |
| 34 | SEPTERNA INC | SEPN | 560,000 | $12.8M | 0.70% |
| 35 | IMMUNITYBIO INC | IBRX | 3,000,000 | $7.7M | 0.42% |
| 36 | ENLIVEN THERAPEUTICS INC | ELVN | 250,000 | $5.6M | 0.31% |
| 37 | ARS PHARMACEUTICALS INC | SPRY | 500,000 | $5.3M | 0.29% |
| 38 | VYNE THERAPEUTICS INC | VYNE | 1,394,336 | $4.7M | 0.26% |
| 39 | KALA BIO INC | KALA | 603,027 | $4.2M | 0.23% |
| 40 | GH RESEARCH PLC | GHRS | 593,043 | $4.2M | 0.23% |
| 41 | Y-MABS THERAPEUTICS INC | 984241109 | 425,000 | $3.3M | 0.18% |
| 42 | UROGEN PHARMA LTD | URGN | 300,000 | $3.2M | 0.18% |
| 43 | OMEROS CORP | OMER | 300,000 | $3.0M | 0.16% |
| 44 | STOKE THERAPEUTICS INC | STOK | 254,161 | $2.8M | 0.15% |
| 45 | BIOHAVEN LTD | BHVN | 55,539 | $2.1M | 0.11% |
| 46 | VERVE THERAPEUTICS INC | 92539P101 | 350,000 | $2.0M | 0.11% |
| 47 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 103,633 | $1.0M | 0.06% |
| 48 | RAPT THERAPEUTICS INC | 75382E109 | 200,000 | $316,000 | 0.02% |